Rucaparib: First Global Approval

Syed, YY

Syed, YY (reprint author), Springer, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2017; 77 (5): 585

Abstract

Rucaparib (Rubraca TM) is an oral, small molecule, poly (ADP-ribose) polymerase inhibitor being developed by Clovis Oncology, Inc. (Boulder, CO, USA) ......

Full Text Link